These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13823694)

  • 1. Reactivation of neostigmine inhibited human plasma cholinesterase.
    FOLDES FF; ERDOS EG; ZSIGMOND EK; ZWARTZ JA
    J Pharmacol Exp Ther; 1960 Aug; 129():394-9. PubMed ID: 13823694
    [No Abstract]   [Full Text] [Related]  

  • 2. Neostigmine and atypical plasma cholinesterase activity.
    Baraka A
    Br J Anaesth; 1981 Aug; 53(8):907-8. PubMed ID: 7272156
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties and behavior of purified human plasma cholinesterase. IV. Enzymatic destruction of the inhibitors prostigmine and physostigmine.
    GOLDSTEIN A; HAMLISCH RE
    Arch Biochem Biophys; 1952 Jan; 35(1):12-22. PubMed ID: 14915538
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity.
    Baraka A; Wakid N; Mansour R; Haddad W
    Br J Anaesth; 1981 Aug; 53(8):849-51. PubMed ID: 7272149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties and behavior of purified human plasma cholinesterase. III. Competitive inhibition by prostigmine and other alkaloids with special reference to differences in kinetic behavior.
    GOLDSTEIN A
    Arch Biochem Biophys; 1951 Nov; 34(1):169-88. PubMed ID: 14904048
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atropine interference of prostigmine effect on human blood cholinesterase].
    MAIER EH
    Klin Wochenschr; 1953 Jan; 31(3-4):91. PubMed ID: 13062582
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of neostigmine and pyridostigmine on serum cholinesterase activity.
    Mirakhur RK; Clarke RS; Collier PS
    Can Anaesth Soc J; 1982 May; 29(3):287. PubMed ID: 7074413
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum cholinesterase activity following pancuronium and antagonism with neostigmine or pyridostigmine.
    Stoelting RK
    Anesthesiology; 1976 Dec; 45(6):674-8. PubMed ID: 984487
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum cholinesterase in anaesthesia with reference to neostigmine, fentanyl, and dihydrobenzpiridol.
    McIntyre JW; Campbell DJ
    Can Anaesth Soc J; 1966 Nov; 13(6):557-61. PubMed ID: 5957441
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutation to neostigmine resistance in a cholinesterase-containing Pseudomonas.
    SEARLE BW; GOLDSTEIN A
    J Bacteriol; 1962 Apr; 83(4):789-96. PubMed ID: 13910213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Persistence of neostigmine-like activity in tissues of the rat after prolonged oral administration.
    Buckley GA; Heading CE
    Br J Pharmacol; 1972 Feb; 44(2):336P-337P. PubMed ID: 4668606
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of suxamethonium, pancuronium, neostigmine and halothane on serum cholinesterase activity.
    Choudhury KJ; Mosuro OS; Ffoulkes-Crabbe DJ
    Middle East J Anaesthesiol; 1989 Oct; 10(3):315-21. PubMed ID: 2637954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the cholinesterase of the chicken. I. Pseudo-cholinesterase of the plasma and diisopropylfluorophosphate-resistant pseudo-cholinesterase of the liver and other tissues.
    Tanabe A; Hori S; Toriumi T; Ikeda M; Urakawa N
    Nihon Juigaku Zasshi; 1971 Apr; 33(2):69-79. PubMed ID: 5105009
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma cholinesterase activity in newborns and infants.
    Zsigmond EK; Downs JR
    Can Anaesth Soc J; 1971 May; 18(3):278-85. PubMed ID: 5578586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aneurine and cholinesterase after inhibition by prostigmine].
    CARDOSO R
    C R Seances Soc Biol Fil; 1951 Nov; 145(21-22):1735-6. PubMed ID: 14926259
    [No Abstract]   [Full Text] [Related]  

  • 17. Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase.
    Robertson WS; Shaikh J; Purdie DW
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():431-3. PubMed ID: 7486808
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of succinyldithiocholine hydrolysis by serum cholinesterase: comparison to dibucaine and succinylcholine numbers.
    Hersh LB; Raj PP; Ohlweiler D
    J Pharmacol Exp Ther; 1974 May; 189(2):544-9. PubMed ID: 4829230
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between the cholinesterase activity of capillaries and the blood-brain barrier in the rat.
    Joó F; Várkonyi T
    Acta Biol Acad Sci Hung; 1969; 20(4):359-72. PubMed ID: 5377318
    [No Abstract]   [Full Text] [Related]  

  • 20. HUMAN TISSUE CHOLINESTERASES: RATES OF RECOVERY AFTER INHIBITION BY NEOSTIGMINE; MICHAELIS-MENTEN CONSTANTS.
    KITZ RJ
    Biochem Pharmacol; 1964 Sep; 13():1275-82. PubMed ID: 14221725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.